Clearside Biomedical, Inc. (CLSDQ)
1.00
-0.04
(-3.85%)
USD |
OTCM |
Dec 16, 16:00
Clearside Biomedical EPS Diluted (Quarterly): -1.141 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 6.211 |
| Mersana Therapeutics, Inc. | -1.511 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.972M |
| Revenue (Quarterly) | 0.201M |
| Total Expenses (Quarterly) | 6.173M |
| Enterprise Value | 60.05M |
| Gross Profit Margin (Quarterly) | 58.21% |
| Profit Margin (Quarterly) | -2.97K% |
| Earnings Yield | -355.9% |
| Normalized Earnings Yield | -355.89 |